Zhengang Shan

Zhengang Shan

Auto-generated profile, based on publicly available information

Zhengang Shan

Guangzhou Blood Center

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Retrovirology
Verified
Journal Article
Open access
PDF file
LCLe Chang
Le Chang
SOShanhai Ou
Shanhai Ou
ZSZhengang Shan
Zhengang Shan
FZFaming Zhu
Faming Zhu
HJHuimin Ji
Huimin Ji
LWLunan Wang
Lunan Wang
Background: So far, the prevalence of human T-lymphotropic virus (HTLV) type 1 and 2 in some highly populated countries such as China is still unknown. In this study, a multi-center nationwide serological survey was designed and performed, to reveal the seroprevalence of HTLV infection among Chinese blood donors. Results: Among 8,411,469 blood donors from 155 blood establishments, 435 were finally confirmed as HTLV carriers. The prevalence of HTLV infection in China varied in different provinces: Fujian had the highest prevalence of 36.240/100,000 (95% CI 31.990–41.050) and eleven provinces did not find HTLV-seropositive donors in the three years. no HTLV-2 infection was found. The overall prevalence of HTLV-1 in China decreased from 2016 to 2018. Female was identified as an independent risk factor of HTLV infection in China. Besides, seroconversion was observed in two of seven seroindeterminate donors 85 and 250 days after their last donation, respectively. Conclusions: The seroprevalence of HTLV infection in most areas of China among blood donors is quite low, but it varies significantly in different geographic areas. Screening anti-HTLV-1/2 antibody and follow-up of serointederminate donors are essential to ensure blood safety especially in areas where we have found HTLV infected donors.

20 July 2017 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
QLQiao Liao
Qiao Liao
ZSZhengang Shan
Zhengang Shan
WMWang Min
Wang Min
JHJieting Huang
Jieting Huang
RXRu Xu
Ru Xu
XRXia Rong
Xia Rong


19 August 2020 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
RXRu Xu
Ru Xu
JHJieting Huang
Jieting Huang
CDChaohui Duan
Chaohui Duan
QLQiao Liao
Qiao Liao
ZSZhengang Shan
Zhengang Shan
HWHao Wang
Hao Wang
Since the first case of COVID‐19 reported in late December of 2019 in Wuhan, China, the SARS‐CoV‐2 virus has caused approximately 20 million infections and 732 thousand deaths around the world by 11 August 2020. Although the pathogen generally infects the respiratory system, whether it is present in the bloodstream and whether it poses a threat to the blood supply during the period of the outbreak is of serious public concern. In this study, we used enzyme‐linked immunosorbent assay (ELISA) to screen total antibodies against SARS‐CoV‐2 in 2199 blood donors, who had donated blood at the Guangzhou Blood Center during the epidemic. The Ig‐reactive samples were further characterized for IgA, IgG, and IgM subtypes by ELISA and viral nucleic acid by real‐time polymerase chain reaction. Among the 2199 plasma samples, seven were reactive under total antibodies' screening. Further testing revealed that none of them had detectable viral nucleic acid or IgM antibody, but two samples contained IgA and IgG. The IgG antibody titers of both positive samples were 1:16 and 1:4, respectively. Our results indicated a low prevalence of past SARS‐CoV‐2 infection in our blood donors, as none of the tests were positive for viral nucleic acid and only 2 out of 2199 (0.09%) of samples were positive for IgG and IgA. There would be a limited necessity for the implementation of such testing in blood screening in a COVID‐19 low‐risk area.

4 February 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
QLQiao Liao
Qiao Liao
ZSZhengang Shan
Zhengang Shan
MWMin Wang
Min Wang
JHJieting Huang
Jieting Huang
RXRu Xu
Ru Xu
YFYongshui Fu
Yongshui Fu
To systematically characterize the prevalence and evolution of human T-cell lymphotropic virus (HTLV) infection among voluntary blood donors (BDs) in Guangdong province, China. A three-year survey for HTLV epidemiology among BDs was performed in Guangdong during 2016–2018. Anti-HTLV-1/2 was screened by ELISA and ECLIA, and subsequently confirmed by western blot (WB) and nucleic acid testing (NAT). The prevalence of HTLV in donors from different cities was calculated. The identified HTLV-positive cases were phylogenetically genotyped and analyzed in a Bayesian phylogenetic framework. Among 3,262,271 BDs, 59 were confirmed positive for HTLV-1 (1.81 per 100,000) and no HTLV-2 infection was found. The prevalence of HTLV-1 varied significantly among 21 cities in Guangdong province, China. The highest prevalence was found in donors from Shanwei (13.94 per 100,000), which is a coastal city in eastern Guangdong. Viral genomic sequences genotyped from 55 HTLV-1 carriers showed that 39 were transcontinental subtype and 16 were Japanese subtype. Specially, 13 out of 39 transcontinental subtype sequences were characterized with L55P mutation and 21 out of 55 sequences were characterized with L19F mutation in viral gp46 protein. The L55P mutation seemed be specific to eastern Asia since it only presented in the sequences from Japan, mainland China, and Taiwan. Phylogenetic analysis of gp46 gene shows that HTLV-1a may have been introduced to Guangdong through four different introduction events and formed major transmission clusters: clades I(13,602 years ago), II(16, 010 years ago), III(15,639 years ago) and IV(16,517 years ago). In general, Guangdong is considered to be a low-prevalence region for HTLV-1 infection, but the prevalence is significantly higher in Shanwei city. Transcontinental and Japanese subtype lineages dominate the prevalence in Guangdong. In terms of blood safety, HTLV antibody screening for first-time blood donors can effectively reduce the risk of HTLV transmission.

23 August 2023 in Research Square
Verified
Preprint
Open access
PDF file
ZSZhengang Shan
Zhengang Shan
JHJieting Huang
Jieting Huang
MWMin Wang
Min Wang
RXRu Xu
Ru Xu
QLQiao Liao
Qiao Liao
XRXia Rong
Xia Rong
Qualified blood from healthy donors may still contain infectious pathogens that could become important threats to human life. The objective of this study was to screen for blood-borne viruses and analyze the virome profiles in plasma via metagenomic sequencing. A total of 1,200 plasma samples were collected and mixed into 12 pools based on sampling time, then DNA and cDNA libraries were constructed for sequencing which was carried out by Illumina NovaSeq 6000 system. After data cleaning and filtering using bioinformatic tools, 2336 viral reads via DNA sequencing and 61985 viral reads via cDNA sequencing were obtained. Seven DNA viruses belonging to three families and one RNA virus were identified from these reads. Most of the viruses found in pooled plasma were considered non- pathogenic, especially anellovirus found in all 12 pools and human pegivirus detected in 7 of the 12 pools. Three pathogenic viruses were found by DNA sequencing, including human herpes virus 6A, human cytomegalovirus and Epstein-Barr virus. All of them belong to the family Herpesviridae and their reads accounted for 7.9% (184/2336). Currently, data on anellovirus and human pegivirus in China are scarce. The herpes virus, which has a high sero-prevalence, is not a mandatory marker for blood screening. This study preliminary elucidated the virome spectra in blood from qualified donors in Guangzhou and contributed to information regarding blood transfusion safety in China.